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Synergistic action of estradiol and PGE2 on endometrial transcriptome in
vivo resembles pregnancy effects better than estradiol alone
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Abstract: Successful pregnancy establishment in mammals depends on numerous interactions between
embryos and the maternal organism. Estradiol-17฀ (E2) is the primary embryonic signal in the pig,
and its importance has been questioned recently. However, E2 is not the only molecule of embryonic
origin. In pigs, prostaglandin E2 (PGE2) is abundantly synthesized and secreted by conceptuses and
endometrium. The present study aimed to determine the role of PGE2 and its simultaneous action
with E2 in changes in porcine endometrial transcriptome during pregnancy establishment. The effects of
PGE2 and PGE2 acting with E2 were studied using an in vivo model of intrauterine hormone infusions,
and were compared to the effects of E2 alone and conceptuses’ presence on day 12 of pregnancy. The
endometrial transcriptome was profiled using gene expression microarrays followed by statistical analyses.
Downstream analyses were performed using bioinformatics tools. Differential expression of selected genes
was verified by quantitative PCR. Microarray analysis revealed 2413 differentially expressed genes (DEGs)
in the endometrium treated simultaneously with PGE2 and E2 (P < 0.01). No significant effect of PGE2
administered alone on endometrial transcriptome was detected. Gene ontology annotations enriched for
DEGs were related to multiple processes such as: focal adhesion, vascularization, cell migration and
proliferation, glucose metabolism, tissue remodeling, and activation of immune response. Simultaneous
administration of E2 and PGE2 induced more changes within endometrial transcriptome characteristic to
pregnancy than infusion of E2 alone. The present findings suggest that synergistic action of estradiol-17฀
and PGE2 resembles the effects of pregnancy on endometrial transcriptome better than E2 alone.
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Kaczynski, Piotr; Bauersachs, Stefan; Goryszewska, Ewelina; Baryla, Monika; Waclawik, Agnieszka
(2021). Synergistic action of estradiol and PGE2 on endometrial transcriptome in vivo resembles preg-






















Title: Synergistic action of estradiol and PGE2 on endometrial transcriptome in vivo 
resembles pregnancy effects better than estradiol alone.   
 
Authors: Piotr Kaczynski 1, Stefan Bauersachs 2, Ewelina Goryszewska 1, Monika Baryla 1, 
Agnieszka Waclawik 1 
1 Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 
Poland;  




















© The Author(s) 2020. Published by Oxford University Press on behalf of Society for the

































































































































Grant Support: This research was funded by National Science Centre, Poland, grant number 
2017/27/B/NZ9/03014 (to AW). Piotr Kaczynski was supported by the grant of KNOW 
Consortium “Healthy Animal—Safe Food”, MS&HE Decision No. 05-1/KNOW2/2015. 
Correspondence: a.waclawik@pan.olsztyn.pl; waclawik@pan.olsztyn.pl; Institute of Animal 
Reproduction and Food Research, Polish Academy of Sciences, Poland, Tuwima 10, 10-748 
Olsztyn, Poland, Tel.: +48-89-5393111 
Running title: Synergistic effect of PGE2 and E2 on endometrium  
Summary sentence: Prostaglandin E2 acting simultaneously with estradiol-17β in vivo 
induces more changes within porcine endometrial transcriptome resembling pregnancy effects 
compared with estradiol-17β administered alone. 
Keywords: early pregnancy; endometrium; pig; prostaglandins; estradiol-17β; transcriptome 
profiling 
Additional footnotes: The presented data have been deposited in National Center for 
Biotechnology Information Gene Expression Omnibus and are accessible through GEO Series 























































































































Successful pregnancy establishment in mammals depends on numerous interactions between 
embryos and the maternal organism. Estradiol-17β (E2) is the primary embryonic signal in the 
pig, and its importance has been questioned recently. However, E2 is not the only molecule of 
embryonic origin. In pigs, prostaglandin E2 (PGE2) is abundantly synthesized and secreted by 
conceptuses and endometrium. The present study aimed to determine the role of PGE2 and its 
simultaneous action with E2 in changes in porcine endometrial transcriptome during 
pregnancy establishment. The effects of PGE2 and PGE2 acting with E2 were studied using 
an in vivo model of intrauterine hormone infusions, and were compared to the effects of E2 
alone and conceptuses’ presence on day 12 of pregnancy. The endometrial transcriptome was 
profiled using gene expression microarrays followed by statistical analyses. Downstream 
analyses were performed using bioinformatics tools. Differential expression of selected genes 
was verified by quantitative PCR. Microarray analysis revealed 2413 differentially expressed 
genes (DEGs) in the endometrium treated simultaneously with PGE2 and E2 (p<0.01). No 
significant effect of PGE2 administered alone on endometrial transcriptome was detected. 
Gene ontology annotations enriched for DEGs were related to multiple processes such as: 
focal adhesion, vascularization, cell migration and proliferation, glucose metabolism, tissue 
remodeling, and activation of immune response. Simultaneous administration of E2 and PGE2 
induced more changes within endometrial transcriptome characteristic to pregnancy than 
infusion of E2 alone. The present findings suggest that synergistic action of estradiol-17β and 
























































































































The peri-implantation period in mammalian species is a critical stage characterized by 
a high risk of pregnancy establishment failure. During this time developing embryos signal 
their presence to the maternal organism by secretion of multiple factors including hormones, 
cytokines, and other molecules (reviewed in [1]). In pigs, the primary embryonic signal is 
estradiol-17β (E2), which is abundantly synthesized and secreted by conceptuses (embryos 
with associating membranes) on days 11–13 and 15–25 post estrus [2, 3]. Elevated estrogens 
synthesis and secretion by porcine conceptuses initiates the maternal recognition of pregnancy 
involving multiple processes, resulting in a prolonged lifespan of corpus luteum and the 
maintenance of progesterone secretion [4]. Progesterone, in turn, induces the uterine 
receptivity that corresponds to the limited period of time during which the uterine luminal 
epithelium is favorable to blastocyst implantation [5].  
 During the maternal recognition of pregnancy, the uterine endometrium undergoes 
rapid morphological and functional changes enabling its readiness for conceptus attachment 
[6, 7]. These changes occurring in the endometrium during the peri-implantation period are 
preceded by dynamic alterations within the endometrial transcriptome [8–11]. Intriguingly, 
recent report based on results from studies involving CYP19A1-deficient porcine embryos 
have contested the role of E2 in early embryonic development, conceptus elongation, 
maternal recognition of pregnancy, attachment to the maternal epithelium, placentation, and 
maintenance of pregnancy until day 30–35 [12]. In contrast, we recently evidenced an 
important role of estradiol-17β in the induction of changes in the global gene expression 
profile of the porcine endometrium in vivo that were characteristic of early pregnancy [13].  
 Embryonic estrogens, however, are not the only molecules involved in the 






















































































































(PGE2) is synthesized and secreted both by conceptuses and the endometrium during the 
period corresponding to the maternal recognition of pregnancy [14–16]. PGE2 acting as a 
conceptus signal mediator has been suggested to be involved in prolonging the corpus luteum 
lifespan during early pregnancy in pigs [17-19]. Moreover, we evidenced that PGE2 acting 
through its receptors in the endometrium during the peri-implantation period stimulates 
conceptus PTGER2 expression and increases the synthesis and secretion of estradiol-17β. 
Additionally, PGE2 enhances integrin-dependent trophoblast adhesion [20]. However, recent 
studies involving prostaglandin-endoperoxide synthase 2 (PTGS2) knockout embryos implied 
that prostaglandins of conceptus origin are not essential for early development and 
establishment of pregnancy in the pig [21]. 
 Our previous studies demonstrate the importance of PGE2 to processes that support 
conceptus attachment to the endometrium for implantation in pigs.  However, recent 
controversial reports potentially diminish the role(s) of PGE2 and E2 in embryonic 
development and the establishment of pregnancy.  Therefore, we aimed to determine whether 
PGE2 may be responsible for inducing changes within the endometrial transcriptome and to 
resolve the synergistic effects of PGE2 and E2 on changes in the global gene expression 
profile during early pregnancy. In our studies we applied an in vivo model of hormonal 
infusions administered directly into the uterine lumen, and included endometrial samples 
collected from gilts on day 12 of pregnancy and the estrous cycle as a reference group. To 
determine the effects of PGE2 and PGE2 acting simultaneously with E2 in changes occurring 
in the porcine endometrium, we performed transcriptome profiling using gene expression 

























































































































2. MATERIALS AND METHODS 
 All procedures involving the use of animals were conducted in accordance with the 
national guidelines for agricultural animal care and were approved by the Animal Ethics 
Committee, University of Warmia and Mazury in Olsztyn, Poland, permission No. 
17/2008. 
1.1. Animal model in vivo 
 Effects of PGE2 administered alone or simultaneously with estradiol-17β were studied 
using a porcine in vivo model. Crossbred gilts at the same age and genetic background, after 
second natural estrous cycle underwent estrus synchronization according to the procedure 
described previously [22]. On day 8-9 of the third natural estrous cycle animals underwent 
surgery as described previously [13, 22]. Briefly, the intrauterine catheter was perforated 
along its length (30 cm silicone tube with a blind end and perforated every 5 cm) in order to 
simulate hormone delivery by embryos. The catheters were introduced into the uterine lumen 
of both uterine horns at a distance of 10 - 15 cm from the isthmus and they did not cover 
whole uterine horn. The catheters were exteriorized through a small flank incision on their 
adjacent side. Mixing between uterine horns was excluded. Animals were then divided in four 
groups (n=5-6 per group). In the control group, each horn received intrauterine placebo 
(vehicle, 5 mL of 1% v/v ethanol saline) infusions. In hormone-treated groups, randomly 
selected horns within each gilt received hormonal infusions: PGE2 (200 µg/infusion; n=6), E2 
(33.3 µg/infusion; n=5), or PGE2 (200 µg/infusion) simultaneously with E2 (33.3 
µg/infusion; n=6). The contralateral horn received placebo infusions. Doses of hormones used 
were similar to those previously published [23-25]. In our previous report [13] we evidenced 
that a lower dose of E2 (833 ng/infusion) resulted in alterations within the endometrial 






















































































































induced greater changes in the global gene expression profile that were more similar to 
changes identified in the endometrial transcriptome on day 12 of the pregnancy. Treatments 
were administered manually by using sterile syringes plugged into exteriorized catheter every 
4 h for 24 h beginning on the morning of day 11 after the onset of estrus. After experiment, on 
day 12 since the estrus, gilts were slaughtered at the local abattoir and uteri were collected. 
Endometrial tissue was dissected from myometrium and snap-frozen in liquid nitrogen, then 
stored at -80 °C until further analyses.  
 
1.2. Total RNA isolation and synthesis of complementary DNA 
 Total RNA was isolated from endometrial samples using TRIzol (Invitrogen, 
Carlsbad, CA, USA) according to the manufacturer’s protocol. Purity and concentration of 
isolated RNA was measured with NanoDrop spectrophotometer (Thermo Fisher Scientific). 
RNA integrity was assessed by using Agilent Eukaryote Total RNA Nano chips and Agilent 
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). To synthesize the cDNA 
for quantitative PCR (qPCR) reaction, a 1 µg of total RNA sample was reverse-transcribed by 
using MultiScribe™ Reverse Transcriptase kit (Thermo Fisher Scientific) according to the 
manufacturer’s protocol. Reverse-transcribed cDNA samples were stored in -80 °C for further 
qPCR analyses. 
 
1.3. Endometrial transcriptome profiling by using expression microarrays 
 Total RNA (100 ng) isolated from endometrial tissues was used in transcriptome 
profiling by using expression microarrays. Cy3-labeled cRNA was generated with the Low-
Input Quick Amp Labeling Kit, one-color (Agilent Technologies) and hybridized to the 






















































































































protocol provided by the producer. Following hybridization and washing slides were scanned 
with an Agilent DNA Microarray Scanner (G2505C; Agilent Technologies) at 2-μm 
resolution. Feature Extraction Software 10.5.1.1 (Agilent Technologies) was used for image 
processing. Expression signals were filtered based on “well above background” flags 
(detection in 5 of 10 samples in control group, and in 5 of 6  samples in experimental group) 
and normalized with the BioConductor package VSN [26]. For quality control, normalized 
data were analyzed with a distance matrix and a heatmap based on pair-wise distances 
(BioConductor package Geneplotter). Probes exhibiting significant differences in signal 
intensity were identified in the contrasts: “hormone-treated horns” (experimental group) vs. 
“placebo-treated horns” (control group) using the BioConductor package LIMMA (Linear 
Model for Microarray Analysis; [27]). Following cut-off’s were applied: log fold change > 
0.585 and P-value < 0.01. For the correction of multiple testing the “FDR”-method (False 
Discovery Rate; FDR 5%, i.e., adjusted P-value < 0.05) was applied. The distribution of 
expression signals of identified probes among samples, was visualized by hierarchical 
clustering using Pearson correlation performed in Multiexperiment Viewer software (MEV; 
[28]). Probes were annotated based on mapping of their sequences (60 nt sequences) to the 
porcine genome (SusScrofa 11.1). Known and potential human ortholog or homolog genes 
were assigned using a ortholog annotation database (Mammalian Ortholog and Annotation 
Database, MAdb; [29]). If a gene in the list was represented by more than one probe 
sequence, the mean of log fold-change, P-value and adjusted P-value (FDR) were calculated. 
The presented data have been deposited in National Center for Biotechnology Information 

























































































































2.4. Functional annotation of microarray results 
 Lists of differentially expressed genes (DEGs) generated by LIMMA analysis was 
used as input data for functional annotation. To study the changes in global gene expression 
profile in endometrial samples treated with PGE2 and E2, we used open-source and 
commercial software. The Database for Annotation, Visualization, and Integrated Discovery 
(DAVID; [30; 31]) was used to calculate the fold enrichment of identified gene ontology 
(GO) terms using the following databases: Functional Categories (UP_KEYWORDS); gene 
ontology Biological Process (GOTERM_BP_FAT), Cellular Component 
(GOTERM_CC_FAT); Molecular Function (GOTERM_MF_FAT); General Annotations 
(SP_COMMENT); Pathways (BIOCARTA; KEGG PATHWAY); Protein Domains 
(INTERPRO); and Protein Interactions (UCSC_TFBS). The results generated by DAVID 
were summarized in a tabular format. 
 To compare transcriptome changes induced by PGE2 and E2 treatment with these 
associated with the pregnancy the expression signals of DEGs identified in endometrial 
samples collected from gilts treated with E2 and PGE2 were matched with the expression 
signals of DEGs identified in endometrial samples collected from gilts on day 12 of 
pregnancy and the estrous cycle [13]. Likewise, the expression signals of DEGs identified in 
endometrial samples collected from gilts on day 12 of pregnancy and the estrous cycle [13] 
were matched with expression signals of genes in dataset generated for endometrial samples 
collected from gilts treated with PGE2 and E2. Generated matrix of matched expression 
signals was then analyzed by hierarchical clustering using Pearson correlation. Common and 
group-specific DEGs were identified using jVenn plug in (jvenn.toulouse.inra.fr; [32]) and 
summarized in a Venn diagram and tabular format. 
 Topp Cluster software [33] was used to identify gene ontologies (GOs) enriched by 






















































































































compared to GOs identified in porcine endometria treated with E2 alone and in endometrial 
samples collected on day 12 of pregnancy (when compared to day 12 of the estrous cycle; 
[13]). Results were summarized in a tabular format and visualized as a relationship network. 
 Ingenuity Pathway Analysis (IPA; v. 01.12; Qiagen, Redwood City, CA, USA) 
software was used to compare canonical pathways, upstream regulators and bio functions 
associated with pregnancy-specific, E2- and PGE2+E2-affected DEGs. Terms with prediction 
Z-score higher than 2 or lower than −2 may be regarded as significant [34]. The results of the 
performed analyzes were summarized in tabular and in graphic formats. 
 
1.4.Validation of microarray results 
 The results of endometrial transcriptome profiling by expression microarrays were 
verified by qPCR (real-time RT-PCR) for following genes: caspase 3 (CASP3); deleted in 
malignant brain tumors 1 (DMBT1); growth differentiation factor 15 (GDF15);  kelch like 
family member 14 (KLHL14); lysophosphatidic acid receptor 3 (LPAR3);  mucin 4, cell 
surface associated (MUC4); prosaposin isoform A (PSAP); serpin family B member 7 
(SERPINB7); solute carrier organic anion transporter family member 2A1 (SLCO2A1); 
secreted phosphoprotein 1 (SPP1); transient receptor potential cation channel subfamily V 
member 6 (TRPV6) and Wnt family member 5A (WNT5A). Quantitative PCR reactions were 
performed using TaqMan assays (Thermo Fisher Scientific; Supplemental Table 1); 
accordingly to the manufacturer’s protocol or using oligonucleotide primers and SYBR Green 
(Thermo Fisher Scientific; Supplemental Table 1). Briefly, reverse-transcribed cDNA (3.5 
µL) was added to the reaction mixture: 12.5 µL Power SYBR Green master mix, 2.5 µL of 
each sense and antisense primer (1 µM; Supplemental Table 1), and 4 µL of nuclease-free 






















































































































initial denaturation (95 °C, 10 min) followed by 36 cycles of denaturation (95 °C; 15 s), 
annealing and elongation (60 °C; 1 min). For WNT5A following PCR program was applied: 
36 cycles of: denaturation (15 s at 95°C), annealing (30 s at 59°C) and elongation (60 s at 
72°C). After PCR using SYBR Green, melting curves were acquired by gradual increases in 
temperature from 60 to 95 °C to ensure that a single product was amplified in the PCR 
reaction. All qPCR reactions were performed with Applied Biosystems 7900HT Real-Time 
PCR system (Life Technologies, Carlsbad, CA, USA). Gene expression was calculated using 
real-time PCR Miner software [35]. Stability of the reference genes in the porcine 
endometrium was assessed using the statistical algorithm Normfinder 2.0 [36]. Six reference 
genes were analyzed: ACTB, GAPDH, HMBS, HPRT1, PPIA, and RPL13A. For normalization 
of the results, the geometrical mean of the most stable pair of reference genes (RPL13A and 
GAPDH) was used. The direct local effect of E2, PGE2 and PGE2 administered 
simultaneously with E2 on endometrial gene expression was studied by comparison of mRNA 
levels in the endometrial samples from the hormone-treated horns to its expression in the 
samples from the placebo-treated horns of each gilt. The local indirect effects of E2, PGE2 
and PGE2 administered simultaneously with E2 on endometrial gene expression were studied 
by comparison of mRNA levels in endometrial samples from the experimental group to the 
levels in the control group (placebo infusions into both horns). 
 
2.6. Statistical analyses 
 To determine statistical significance of gene expression difference in the porcine 
endometrium on day 12 of pregnancy compared to day 12 of the estrous cycle the T-test was 
applied. Two-way ANOVA followed by the Bonferroni post-test was used to analyze the 
effect of E2 and PGE2 acting alone or simultaneously with E2 on gene expression in 






















































































































statistically significant at the 95% confidence level (p<0.05). All statistical analyses were 




2.1.Porcine endometrial transcriptome profiling using microarrays 
Global gene expression profiling in porcine endometrium towards PGE2 treatment and 
simultaneous treatment with PGE2 (200 µg/ infusion) and estradiol-17β (33.3μg / infusion) in 
vivo compared to placebo (saline) treatment was determined using the porcine Agilent 
microarray assay. The numbers of detected probes passing the filters were as follows: 37 408 
(PGE2-treated vs. placebo-treated) and 38 267 (E2+PGE2-treated vs. placebo-treated). 
Pairwise distance analysis based on all detectable probes revealed that endometrial samples 
treated with PGE2 represented mainly random grouping (Supplemental Figure 1A) whereas 
endometrial samples treated with PGE2 together with E2 represented mainly treatment 
grouping with a slight bias observed in the heatmap (Supplemental Figure 1B).  
Comparing the effect of simultaneous infusion of PGE2 and E2 using LIMMA 
package, 4487 probes displayed significant differences in expression signal intensities (fold 
change </>1.5; p < 0.01; false discovery rate (FDR) = 5%). Collapsing the results from the 
probe level to the gene level revealed 2413 differentially expressed genes (DEGs; Figure 1). 
No probes expressing significant differences in expression signal intensity (fold change 
</>1.5; p < 0.01; false discovery rate (FDR) = 5%) were detected for endometrial samples 
treated with PGE2. The results of statistical analysis of microarray data are summarized in 
Supplemental Table 2. The Pearson correlation performed for DEGs detected in endometrial 
samples treated simultaneously with E2 and PGE2 revealed treatment grouping of the 






















































































































expression signals (Figure 1). In the endometrial samples collected from horns receiving 
hormonal infusion (33.3 μg of E2 + 200 µg of PGE2/infusion), the five DEGs showing the 
highest upregulation in the pairwise comparison “E2+PGE2-treated horns” of the 
experimental group vs. “placebo-treated horns” of the control group were: S100 calcium-
binding protein A8 (S100A8; 75-fold), SERPINB7 (47-fold), S100 calcium-binding protein 
A9 (S100A9; 44-fold), aconitate decarboxylase 1 (ACOD1; IRG1; 33-fold) and S100 calcium-
binding protein (S100A12; 26-fold) whereas the five DEGs showing the highest 
downregulation were: interleukin 24 (IL24; -31-fold), opticin (OPTC; -15-fold), ATPase H+ 
transporting V1 subunit G3 (ATP6V1G3; -14-fold), C1q and TNF related 3 (C1QTNF3; -13-
fold) and regenerating family member 3 gamma (REG3G; -12-fold). In Figure 2 top ten 
differentially regulated genes detected in porcine endometrium towards E2+PGE2 treatment 
were compared with  top ten differentially expressed genes identified in porcine endometrium 
treated with E2 alone (33.3 μg/infusion) and top ten DEGs identified in endometrial samples 
collected from gilts on day 12 of pregnancy [13]. 
 
2.2.Functional Annotation of Microarray Data 
 Functional terms enriched for up-regulated and down-regulated DEGs detected in 
endometrial samples treated with E2 together with PGE2 were identified by using the 
DAVID. For up-regulated DEGs DAVID identified 144 annotation clusters (enrichment score 
37.2–1.3) whereas for down-regulated genes 49 annotation clusters (enrichment score 5.6–
1.3) were identified. 
 The most interesting functional terms of overrepresented annotation clusters enriched 
for up-regulated genes were related to focal adhesion, cell migration, glucose metabolic 






















































































































1). For pregnancy-associated down-regulated genes, the most interesting enriched terms were 
related to regulation of transcription and RNA biosynthetic processes, cell morphogenesis and 
histone acetylation, calcium transport and BMP signaling pathway (Table 1). The complete 
results from the functional annotation clustering performed for pregnancy-associated DEGs 
are summarized in Supplemental Table 3. 
 
2.3.Modulatory effect of PGE2 acting simultaneously with estradiol-17β compared with the 
effect of estradiol-17β and day 12 of pregnancy on endometrial transcriptome in the pig 
Using jVenn tool we compared the lists of up- and down-regulated genes identified in the 
endometrial transcriptome profiling. Comparison analyses revealed that PGE2 administered 
into the uterine lumen together with E2 stimulated expression of 83 genes that were found to 
be up-regulated in porcine endometrium on day 12 of pregnancy whereas E2 administered 
alone stimulated 20 genes which were up-regulated in day 12 of pregnancy endometrial 
samples (Fig. 3A). PGE2 acting simultaneously with E2 lowered the expression of 40 genes 
that were also found to be down-regulated in endometrial samples collected on day 12 of 
pregnancy whereas estradiol-17β acting alone lowered the expression of 10 genes that were 
found to be down-regulated in endometrium on day 12 of pregnancy (Fig. 3B). Results of 
comparison analyses are presented in Venn diagrams in Figure 3. Complete results containing 
lists of DEGs are summarized in tabular format in Supplemental Table 4. 
 To compare the changes in endometrial transcriptome evoked by E2 and PGE2 acting 
simultaneously with E2 to those observed on day 12 of pregnancy we used Pearson 
correlation analysis. We observed that the intrauterine infusions of either E2 and PGE2 
together with E2 resulted in grouping of samples close to samples collected from gilts on day 






















































































































samples collected on day 12 of the estrous cycle. However, the scale of changes within the 
endometrial transcriptome was much larger in the endometrial samples treated with PGE2 and 
E2 (Figure 4A) than in samples treated only with E2 (Figure 4B). 
 
2.4.Functional analysis of transcriptome changes evoked by synergistic effect of PGE2 and 
E2 in vivo 
 Using ToppCluster tool we compared gene ontology terms (Biological Process, 
Molecular Function, Cellular Component) and pathways enriched for DEGs identified in the 
endometrial samples treated in vivo with PGE2+E2, E2 alone and for DEGs identified in the 
endometrial samples collected on day 12 of pregnancy. Results of this analysis showed that 
the majority of identified enriched terms were shared by all analyzed groups (Day 12 of 
pregnancy, PGE2 acting simultaneously with E2 and E2 administered alone). However, a 
number of terms and pathways were found to be enriched only for DEGs identified in the 
endometrial samples on day 12 of pregnancy and in the endometrial samples treated with 
PGE2 together with E2. These were related to embryo implantation, fibroblast migration, 
water homeostasis or regulation of extent of cell growth, organ growth, serine/threonine-
protein kinase PLK1 signaling, collagen biosynthesis and others. The most interesting 
identified terms were summarized in graphical format in Figure 5. Complete results were 
summarized in tabular format in Supplemental Table 5.  
 Using Ingenuity Pathway Analysis we performed Comparison Analyses for Canonical 
Pathways and Diseases and Biofunctions enriched for DEGs identified in analyzed groups 
(Day 12 of pregnancy, E2+PGE2 and E2 alone). We compared Z-score values of identified 
terms. We found that PGE2 administered into the uterine lumen together with E2 augmented a 






















































































































(vascular endothelial growth factor (VEGF) signaling and VEGF family ligand-receptor 
interactions, prolactin signaling, eNOS signaling and many others (Fig. 6A). Comparing 
diseases and functions it was demonstrated that PGE2 acting simultaneously with E2 
modulated a Z-score value for such functions as cell movement and migration, inflammatory 
response, transport of molecules, fibrogenesis, proliferation of connective tissue cells, 
apoptosis and many others (Fig. 6B). The most interesting terms were summarized in Figure 
6A and B. Complete results of comparison analyses performed in IPA software are 
summarized in Supplemental Tables 6 and 7. 
 Comparing results of Functional Annotation Clustering performed in DAVID for 
DEGs identified in endometrial samples treated either with PGE2 together with E2 and treated 
only with E2 we selected group-specific terms enriched for DEGs in analyzed gene sets (Fig. 
6C). The most interesting terms enriched for genes up-regulated due to modulatory effect of 
synergistic action of PGE2 and E2 were related to tissue morphogenesis, response to insulin, 
metallopeptidase activity, vasodilation, cell adhesion mediated by integrins and others 
whereas terms enriched for down-regulated genes were related to circadian entrainment, 
regulation of histone methylation or regulation of RNA biosynthetic process. 
 
2.5.Validation of microarray results  
The expression of the following DEGs identified in analyzed groups (Day 12 of the 
estrous cycle/ pregnancy, PGE2, E2 or PGE2 administered together with E2 was validated 
using quantitative PCR (real-time RT-PCR; qPCR): CASP3, DMBT1, GDF15,  KLHL14, 
LPAR3,  MUC4, PSAP, SERPINB7, SLCO2A1, SPP1, TRPV6 and WNT5A. Overall, qPCR 
analysis confirmed the pattern of gene expression detected using expression microarrays in 






















































































































be lowered either by E2 administered alone and acting simultaneously with PGE2 (p<0.05; 
Fig. 7C and L). Intrauterine infusions of E2 and E2 administered together with PGE2 resulted 
in elevated expression of DMBT1, TRPV6, and SERPINB7 genes (p<0.05; Fig. 7B, K and H). 
Administration of PGE2 together with E2 modulated down-regulation of KLHL14 and up-
regulation of SPP1 genes (p<0.05; Fig. 7 D and J). Expression of LPAR3, MUC4, PSAP, and 
SLCO2A1 was found to be stimulated only by synergistic action of PGE2 with E2 (p<0.05; 
Fig. 7 E, F, G and  I). Interestingly, expression of CASP3 was found to be regulated only by 
PGE2 administered alone but not in other treatments (p<0.05; Fig. 7A). Expression patterns of 
genes analyzed in endometrial samples collected on day 12 of the estrous cycle and pregnancy 




 During pregnancy establishment, the endometrium undergoes rapid morphological and 
functional transitions to develop receptivity for embryo implantation. These are preceded by 
changes in the global gene expression profile. Previous reports on endometrial transcriptome 
profiling in the pig revealed a large number of differentially expressed genes involved in 
multiple processes vital for pregnancy establishment and development [8–11, 37]. This is the 
first report studying the synergistic effect of E2 and PGE2 — the hormones which have been 
recently suggested as two maternal recognition signals [1, 12, 20, 21]. The present study 
involves a novel approach of studying the effect of hormones administered in vivo directly 
into the uterine lumen, which imitates the secretion of E2 and PGE2 by conceptuses during 
the time corresponding to the maternal recognition of pregnancy. Recently, we reported that 
estradiol-17β, which is the main embryonic signal in the pig, is responsible for major changes 






















































































































We also indicated that prostaglandin E2 is a key factor involved in controlling reproductive 
function at the embryo–maternal interface (reviewed in [1]). In the present study, we 
evidenced for the first time that PGE2 acting synergistically with E2 in the porcine 
endometrium in vivo, induces substantial changes in global gene expression profile. Utilizing 
an in vivo model of hormonal infusions directly into the uterine lumen, we demonstrated that 
PGE2 administered together with E2 altered the expression of 2413 genes, whereas 
administration of E2 alone altered the expression of 1957 genes [13]. In further analyses we 
applied Venn diagrams to compare DEGs common to in vivo groups (E2, and E2+PGE2), and 
day 12 of pregnancy served as a referential group. These analyses revealed that administration 
of PGE2 together with E2 resulted in a higher number of DEGs that were also identified in 
endometrial samples collected from gilts on day 12 of pregnancy compared with DEGs 
altered by E2 acting alone. However, administration of only PGE2 had no effect on the global 
gene expression profile in the porcine endometrium. These results clearly indicate the 
modulatory effect of PGE2 augmenting the changes induced by E2. Our data are consistent 
with conclusions based on a recent study indicating that both PGE2 and E2 act as maternal 
recognition signals [12, 21]. However, conceptus production of estrogen is essential for 
successful maintenance of pregnancy beyond day 30 because prostaglandins of conceptus and 
endometrial origin are not successful in compensating for ablated estrogen production at this 
time [21]. However, porcine conceptuses are not the only source of estrogens in the uterine 
environment. Active estrogen synthesis and secretion by the myometrium and endometrium 
have been indicated as alternative sources for this signal for recognition of pregnancy in the 
pig [38]. Similarly, our results confirmed that PGE2 is also synthesized and secreted in the 
porcine endometrium and its endometrial synthesis and secretion is stimulated by estradiol-
17β and PGE2 of conceptus origin [14, 16]. Hence, based on the aforementioned studies, it 






















































































































compensated by endometrial E2 and/or PGE2 synthesis and secretion, which in the absence of 
conceptus production of either E2 or PGE2, is sufficient to support the establishment of 
pregnancy and conceptus maintenance until days 30-35 of pregnancy.  
 
4.1. Functional analysis of synergistic effect of E2 and PGE2 on global gene expression 
profile 
 
 Functional annotation analyses of DEGs affected by the synergistic effect of PGE2 
and E2 identified the processes which have been described to be enriched either for 
pregnancy-specific or E2-affected DEGs: extracellular secretion, vasculature development, 
cell adhesion, migration and proliferation, regulation of immune response, regulation of 
transcription, and many others [8–11, 13]. Interestingly, analyses performed by Ingenuity 
Pathway Analysis software allow for comparison of activation/inhibition prediction factor (Z-
score) calculated for identified terms (canonical pathways, diseases, and bio-functions). Our 
results revealed that simultaneous administration of PGE2 and E2 modified (enhanced or 
reduced) the value of the Z-score calculated for several terms. Comparing the canonical 
pathways related with DEGs we found that the addition of PGE2 increased the Z-score 
calculated for pathways related with processes involving pregnancy establishment on day 12 
such as angiogenesis (VEGF signaling, VEGF ligand receptors family, eNOS signaling), 
hormone action (prolactin signaling), tissue remodeling (actin cytoskeleton signaling), and 
energetic processes (glycolysis, gluconeogenesis, and insulin receptor signaling). Similarly, 
simultaneous administration of PGE2 with E2 modulated the Z-score value calculated for bio-
functions involved in the embryo–maternal dialogue, as well as those vital for preparation of 






















































































































response, vasculogenesis, transport of molecules, cell proliferation, secretion of molecules, 
necrosis, and apoptosis. 
 Comparison analyses of identified gene ontology terms, in addition to comparison of 
activation/inhibition prediction factors, allowed the processes related to the synergistic action 
of PGE2 with E2 to be extracted. Using ToppCluster we identified PGE2+E2-specific GO 
terms related to biological processes (i.e., organ growth, embryo implantation, water 
homeostasis), cellular components (chromosome centromeric regions, cyclin-dependent 
protein kinase holoenzyme complex, filopodium membrane), molecular functions (fibrinogen 
binding, G-protein coupled glutamate receptor binding or PDGF binding). Our findings also 
suggest that synergistic action of PGE2 together with E2 affects the pathways involved in 
tissue remodeling (collagen biosynthesis and modifying enzymes) and cell division (PLK1 
signaling events, aurora B signaling). Polo-like kinase (PLK) is a highly conserved 
serine/threonine protein kinase with a highly homologous serine/threonine kinase domain at 
its N-terminus, which regulates PLK activity and subcellular dynamics at the C-terminus and 
targeted polo-box domain (PBD). PLK proteins have been described to regulate many key 
steps in the cell cycle, including the formation of bipolar spindles, chromosome segregation, 
late regulation of complexes, and cytokinesis [39]. Aurora B kinase is a protein that functions 
in the attachment of the mitotic spindle to the centromere and has been reported as a 
necessary factor in cytokinesis [40].  
 In the present study we also compared the results from functional annotation analysis 
performed in DAVID separately for E2– and E2+PGE2-affected DEGs. Removing the 
processes identified for both analyzed groups allowed the processes characteristic only for 
simultaneous action of PGE2 and E2 to be extracted. Terms identified for up-regulated genes 
were related, among others, to tissue morphogenesis, cell adhesions, development of 






















































































































binding, whereas terms enriched for down-regulated genes identified for the synergistic effect 
of E2 and PGE2 were related to DNA binding, regulation of RNA biosynthesis, or circadian 
entrainment. In summary, using various bioinformatics tools we obtained consistent results 
evidencing that PGE2 acting simultaneously with E2 strengthened the effect of E2 on changes 
in the global gene expression profile in the porcine endometrium, affecting the processes 
related to changes in tissue rearrangements, immune response, cell cycle, and energy balance, 
which are critical for successful pregnancy establishment. Moreover, changes in the 
endometrial transcriptome induced by the synergistic action of PGE2 with E2 better 
resembled the changes identified in the porcine endometrium during early pregnancy 
compared to the E2 action alone. 
 
4.2. The local direct and indirect effects of E2 and E2 acting together with PGE2 on the 
endometrial expression of genes involved in pregnancy establishment and development 
 Validation of microarray results using qPCR revealed that, in contrast to the effect of 
E2, only the synergistic action of PGE2 and 2 on the endometrial gene expression of LPAR3, 
MUC4, PSAP, and SLCO2A1 reflected the effect of pregnancy on day 12 on the expression of 
these genes. PGE2 augmented the stimulating effect of E2 on SPP1 expression in the 
endometrium corresponding to expression on day 12 of pregnancy. PGE2 acting together with 
E2 altered the expression of DMBT1, GDF15, KLHL14, SERPINB7, TRPV6, and WNT5A 
genes to the similar extent as E2 administered alone and the pregnancy effect.  
 The most frequent processes enriched for pregnancy-specific, E2–, and E2+PGE2–
affected DEGs were found to be related to ion and molecule transport, immune response, 
tissue remodeling, cell adhesion, proliferation, and differentiation, which are crucial for 
pregnancy establishment in pigs. Comparison of functional annotation analyses revealed that 






















































































































These processes support a proper supply of endometrial tissue with nutrients and factors 
regulating its function. In the present study, we demonstrated that the synergistic action of 
PGE2 with E2 in vivo increased the gene expression of SLCO2A1, which serves as a 
prostaglandin transporter. Our recent reports indicated a vital role for prostaglandins (PGE2 
and PGF2α) in the establishment and development of pregnancy [1, 22, 41–44]. The 
stimulating effect of E2 acting simultaneously with PGE2 on the expression of SLCO2A1 is 
the more interesting result, especially when we take into consideration our description of the 
role of E2 and PGE2 in the mechanism of the PGE2-positive feedback loop in the porcine 
endometrium [16].  
 The molecules acting at the embryo–maternal interface to exert their actions require 
mechanisms transducing their signaling. A number of intracellular processes enriched for 
identified DEGs were related to signaling involving calcium ions. During the peri-
implantation period in pigs the elevated concentration of calcium ions in the uterine lumen 
has been observed [45]. Recently, we reported the stimulating effect of E2 on the TRPV6 gene 
[13], which has been implicated in mediating calcium ion uptake [46]. Moreover, greater 
expression of TPRV6 in the porcine endometrium during early pregnancy has been described 
[47] and indicated as the marker of uterine receptivity. Interestingly, in the present study, we 
evidenced that administration of PGE2 together with E2 amplified the stimulating effect of E2 
on TRPV6 expression.  
 Inflammatory mediators are the key players ensuring a proper immune response of the 
maternal organism to developing embryos. Indeed, the processes related to immune response 
have been enriched for pregnancy-related endometrial DEGs [8–11, 13]. Hormones (i.e., E2), 
cytokines (interleukins, interferons), and prostaglandins are involved in the establishment of 
this proinflammatory environment (reviewed in [1] and [48]). Proteins belonging to the 






















































































































reproductive tissues in cattle [49]. Interestingly, the SERPINB7 gene has been described to be 
up-regulated in the endometrium in reports on porcine endometrial transcriptome profiling [8, 
9]. Using an in vivo model of hormonal infusions directly into the uterine lumen, we 
demonstrated that PGE2 administered together with E2 had a direct stimulating local effect on 
SERPINB7 gene expression, which is also consistent with its expression profile in the porcine 
endometrium on day 12 of pregnancy [13]. Prosaposin (PSAP) is a multifunctional protein 
whose role has been mainly described for the nervous system [50]. However, gene ontology 
analyses linked PSAP with processes related to innate immunity. Synergistic action of E2 and 
PGE2 modulated the stimulating effect of E2 on PSAP gene expression, which was also 
consistent with the expression profile of these genes in day 12 of pregnancy endometrial 
samples. Kelch Like Family Member 14 (KLHL14) has been described to be involved in a 
variety of cellular mechanisms such as control of cytoskeletal organization [51], ion channel 
[52], transcription suppression [53], and lymphocytes B-1a development in mice [54]. 
Previously we reported a diminishing effect of E2 on the expression of the KLHL14 gene in 
vivo [13]. In the present study, we found that PGE2 acting together with E2 also led to 
decreased levels of KLHL14 mRNA content, however, this effect was not as strong as the 
effect of E2 administered alone. These results suggest that PGE2, by acting in addition with 
E2, may be involved in the modulation of the proinflammatory environment in the porcine 
endometrium during early pregnancy. 
 Results of studies of endometrial transcriptome profiling revealed a number of 
processes related to tissue remodeling. Indeed, during early pregnancy the endometrial tissue 
undergoes rapid structural and morphological changes to enable the attachment of 
conceptuses to its surface. These changes are orchestrated by a variety of factors [1, 48]. 
Mucin 4 (MUC4), a high-molecular weight glycoprotein, has been indicated to be responsible 






















































































































expression is increased during the luteal phase and reduced during early proestrus [56]. 
Interestingly, its elevated expression has been found on days 12 and 14 of pregnancy 
compared to days 12 and 14 of the estrous cycle [8, 10]. Considering these findings, authors 
hypothesized that MUC4 may be involved in protecting the epithelial layer of the 
endometrium against invasive trophoblast. Recently, we reported no effect of E2 (33.3 
µg/infusion) on MUC4 expression in vivo [13]. However, in the present study, we found that 
simultaneous administration of PGE2 and E2 into the uterine lumen significantly increased 
the endometrial expression of the MUC4 gene, which was consistent with its elevated 
expression on day 12 of pregnancy [13]. Another DEG that has been linked with GO related 
to tissue remodeling is growth differentiation factor 15 (GDF15), which is a member of the 
transforming growth factor beta (TGFB) superfamily [57]. It has been described to be 
abundantly expressed in the human placenta [58, 59]. Several reports indicate that GDF15 
may be involved in actin cytoskeleton reorganization and remodeling [60]. It has been also 
suggested to be a necessary molecule for the maintenance of pregnancy in humans [61] and 
rats [62]. In our previous report we documented that E2 lowered the expression of GDF15 in 
the porcine endometrium in vivo [13]. Herein, we evidenced that synergistic action of E2 
together with PGE2 decreased the levels of GDF15 mRNA in a direct local manner. GDF15 
participates in placenta development via promoting trophoblast cell invasion [63]; therefore, 
we assume the hypothesis that the down-regulation of GDF15 in the porcine endometrium in 
response to E2 and E2 acting together with PGE2 may be involved in the mechanisms 
protecting the porcine endometrium from invasion of trophoblast into the uterine wall. 
 Cell proliferation, adhesion, migration, and differentiation are the processes 
accompanying tissue remodeling. In our previous report, using porcine and human in vitro 
models we evidenced that PGE2 affecting integrin receptors, expression of focal adhesion 






















































































































extracellular matrix proteins [20]. Functional annotation analyses performed in the present 
study for transcriptome profiling results revealed that cell adhesion was strongly enriched for 
DEG identified in the endometrial samples treated simultaneously with E2 and PGE2. 
Secreted phosphoprotein 1 (SPP1) has been suggested to be the main contributor to stable 
adhesion during the peri-implantation period [64]. Binding of SPP1 to these various receptors 
is involved in diverse effects, including cell-to-cell and cell-to-extracellular matrix adhesion, 
endothelial cell chemotaxis, and endothelial and epithelial cell survival [65]. In the present 
study, we evidenced that E2 administered alone stimulated expression of the SPP1 gene in an 
indirect local manner – both in placebo and E2-treated horns compared to its expression in 
endometrial samples collected from animals of the control group (placebo infusions into both 
uterine horns). It is consistent with findings that systemic administration of estrogens induces 
endometrial expression of SPP1 [66]. Interestingly, presented results indicate that PGE2 
enhanced the stimulating effect of E2 on SPP1 expression. These results strongly support our 
hypothesis that PGE2 is a molecule involved in cell adhesion [20]. DMBT1 has been 
described to be involved in cell proliferation and differentiation. Results of studies on primate 
and rodent uteri revealed that DMBT1 is a protein induced by E2 and was localized to the 
epithelial layer of the endometrium. It has been also suggested to be involved in endometrial 
growth and/or differentiation [67]. Recently, we demonstrated that expression of DMBT1 is 
up-regulated in the porcine endometrium on day 12 of pregnancy and that this up-regulation 
was induced by E2. In the present study, we found that simultaneous administration of E2 
together with PGE2 led to up-regulation of DMBT1 gene to the same extent as E2 
administered alone. Lysophosphatic acid (LPA) is an important factor influencing several 
physiological processes involved in the reproductive function of the female (reviewed in 
[68]). Its receptor (LPAR3) has been proposed to be a uterine receptivity marker critical for 






















































































































differentiation of porcine trophoblast cells by activating the ERK1/2-P90RSK-RPS6 and P38 
pathways. Due to this fact it has been suggested that LPA-LPAR3 signaling is involved in the 
development of the trophoblast during early pregnancy in pigs [70]. Recently, we reported the 
stimulating effect of E2 on endometrial LPAR3 expression in the pig in vivo [13]. In the 
present study, however, we found that simultaneous administration of E2 together with PGE2 
into the uterine lumen increased LPAR3 expression to a higher extent than E2 administered 
alone. These results are also consistent with the elevated expression of LPAR3 detected in the 
porcine endometrium on day 12 of pregnancy [13].  
 Apoptosis is a process closely related to tissue remodeling. The morphological 
changes observed in cells undergoing apoptosis are the final result of the activation of specific 
enzymes known as “caspases”. Caspases-2, -3, and -10 were reported to be exclusively 
associated with apoptosis. Activation of caspase-3 has been linked with the phenomenon of 
irreversible cell death [71]. In the present study, PGE2 administered alone increased the 
CASP3 mRNA content, which was also consistent with the elevated expression of CASP3 in 
the endometrial samples collected from gilts on day 12 of pregnancy [13].  
 Developmental changes of the porcine endometrium are also associated with the 
expression of WNT5A gene as described earlier [72, 73]. Studies performed in the human 
endometrium indicate that WNT signaling may support the glandular function and stromal 
transformation [74]). Our recent results revealed that intrauterine infusions of E2 resulted in 
down-regulation of the WNT5A gene in the porcine endometrium [13]. Administration of E2 
together with PGE2 also resulted in lowered content of WNT5A mRNA, which is consistent 
with the lower expression of the WNT5A gene detected in the porcine endometrium on day 12 
of pregnancy (compared to day 12 of the estrous cycle). However, to determine the biological 
























































































































 Summarizing, the results of transcriptome profiling and gene expression analyses fully 
evidenced that PGE2 augments the effect of E2 on changes in the endometrial transcriptome 
during early pregnancy in the pig. Our present findings suggest that the synergistic action of 
estradiol-17β and prostaglandin E2 resembles the pregnancy effects on the endometrial 
transcriptome better than E2 administered alone. The results presented in this study strongly 
support our hypothesis that both E2 and PGE2 act as mediators of conceptus signaling 
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Figure 1. Changes in global gene expression profile detected in the endometrial samples 
treated simultaneously with E2 (33.3 μg/ infusion) and PGE2 (200 µg/ infusion). Data are 
shown as a heatmap of hierarchical clustering (Pearson correlation) of the normalized values 
of the intensity of the expression signals of probes detected as significantly changed (log fold 
change >0.585; p nominal <0.01; false discovery rate (FDR) = 5%) in the analyzed groups. 
CTRL-endometrial samples collected from gilts assigned to the control groups (infusions of 
placebo to both uterine horns), EX_C-endometrial samples collected from gilts assigned to the 
experimental group (uterine horns receiving placebo infusions), EX_H-endometrial samples 
collected from gilts assigned to the experimental group (uterine horns receiving infusions of 
PGE2 with E2). In the control group, each horn received intrauterine placebo infusions. In 
experimental group, randomly selected horns within each gilt received hormonal infusions of 
PGE2 (200 µg/infusion) simultaneously with E2 (33.3 µg/infusion) whereas the contralateral 













































































































































































































































Figure 2. Heatmap of the log2 fold changes of the top 10 differentially expressed genes 
detected in the endometrial samples collected from gilts treated with estradiol-17β (33.3 μg/ 
infusion; Kaczynski et al., 2020), estradiol-17β (33.3 μg / infusion)  together with 
prostaglandin E2 (PGE2; 200 µg/ infusion) and in the endometrial samples collected from 
gilts on day 12 of pregnancy [13]. The scale is from log2 fold change -5 (blue, down-
regulated) to 9 (red, up-regulated). Each row represents one gene, and each column represents 













































































































































































































































Figure 3. The results of comparison analyses of DEGs identified in endometrial samples 
treated in vivo with E2 and E2+PGE2 and in endometrial samples collected from gilts on day 
12 of pregnancy. Comparisons were performed separately for up - (A) and down-regulated 

























































































































Figure 4. (A) Comparison of transcriptome changes induced by the effect of intrauterine 
administration of PGE2 (200 µg/infusion) together with estradiol-17β (33.3 μg of 
E2/infusion) with those detected in the endometrial samples collected from gilts on day 12 of 
the estrous cycle and pregnancy. (B) Comparison of transcriptome changes induced by the 
effect of intrauterine administration of estradiol-17β administered alone (33.3 μg of 
E2/infusion) ) with pregnancy-effect on day 12 (modified from [13]). Data are shown as a 
heatmap of hierarchical clustering (Pearson correlation) of the normalized values of the 
intensity of the expression signals of probes detected as significantly changed (log fold 
change > 0.585; p nominal < 0.05 false discovery rate (FDR) = 5%) in analyzed groups. 
Cyclic-endometrial samples collected on day 12 of the estrous cycle, pregnant-endometrial 
samples collected on day 12 of pregnancy, CTRL-endometrial samples collected from gilts 
assigned to the control groups (infusions of placebo into both uterine horns), EX_H-
endometrial samples collected from gilts assigned to the experimental group (uterine horns 
receiving PGE2+E2 or E2 infusions), EX_C-endometrial samples collected from gilts 













































































































































































































































Figure 5. A functional map showing shared and group-specific functional annotation terms 
generated in multi-cluster gene functional enrichment analysis for differentially expressed 
genes (DEGs) identified in porcine endometrial samples collected on day 12 of pregnancy and 
treated with PGE2 (200 µg/infusion) together with E2 (33.3 μg/infusion) or with E2 alone 
(33.3 μg/infusion). Analysis was performed in ToppCluster software, the functional map was 
edited and adjusted using Cytoscape. The redundant and noninformative terms were manually 
























































































































Figure 6. Results of comparison analyses performed for results generated by the Ingenuity 
Pathway Analysis (A) and DAVID Functional Annotation Clustering (B). Selected terms of 
Canonical Pathways and Diseases and Biofunctions sections (IPA) are presented together with 
Z-score values. A Z-score value higher than 2 means that the enriched pathway or enriched 
function is significantly activated or stimulated. A Z-score value lower than 2 means that the 
enriched pathway (A) or enriched function (B) is significantly inhibited or suppressed. Grey 
color indicates there is no data allowing for activation/suppression or stimulation/inhibition 
prediction of the enriched term. Functional annotation terms specific for modulatory effect of 
PGE2 acting together with E2 on global gene expression profile in the porcine endometrium 
are presented as bar charts generated separately for terms enriched for up- and down-regulated 
genes (C). Fold enrichment and -Log of p-value calculated for each term are represented by 












































































































































































































































Figure 7. Expression of selected target genes determined by real-time RT-PCR in porcine 
endometrial samples treated in vivo with a placebo (control) or E2 (33.3 μg/infusion) or E2 
(33.3 μg/infusion) together with PGE2 (200 µg/infusion) and on day 12 of the estrous cycle 
(D12 Cyclic) and pregnancy (D12 Pregnant). Data are presented as the mean ± SEM. The 
expression of genes was normalized against the geometrical mean of RPL13A and GAPDH 
expression values. Different letters indicate statistically significant differences (two-way 
ANOVA, followed by the Bonferroni post-test; p<0.05) in the local-indirect effects of 
E2+PGE2, E2 or PGE2 on gene expression. Asterisks (* p<0.05; ** p<0.01) indicate the 
significant differences within the direct local effects of E2+PGE2, E2, or PGE2  on gene 
expression. (A) caspase 3 (CASP3); (B) deleted in malignant brain tumors 1 (DMBT1); (C) 
growth differentiation factor 15 (GDF15); (D) kelch like family member 14 (KLHL14); (E) 
lysophosphatidic acid receptor 3 (LPAR3);  (F) mucin 4, cell surface associated (MUC4); (G) 
prosaposin isoform A (PSAP); (H) serpin family B member 7 (SERPINB7); (I) solute carrier 
organic anion transporter family member 2A1 (SLCO2A1) ); (J) secreted phosphoprotein 1 
(SPP1); (K) transient receptor potential cation channel subfamily V member 6 (TRPV6); (L) 
Wnt family member 5A (WNT5A). Results of gene expression on day 12 of the estrous cycle 





































































































































































































































































































































































Table 1. The selected results of DAVID functional annotation clustering for differentially  
expressed genes in the porcine endometrium in response to synergistic action of E2 and 
PGE2. 





UP REGULATED  
Extracellular exosome (405; 1.84) extracellular vesicle (405; 1.83) 37.20 
Focal adhesion (80; 2.61) 14.58 
Vasculature development (98; 2.26); blood vessel development (94; 2.30); 
angiogenesis (75; 2.56) 
11.64 
Cell migration (153; 1.82) 11.06 
Glucose metabolic process (37; 2.73) 8.41 
Regulation of signal transduction (265; 1.37) 8.23 
Mitotic cell cycle (122; 1.78); cell cycle process (141; 1.46) 7.93 
Regulation of protein phosphorylation (138; 1.50) 6.27 
Antigen processing and presentation (38; 2.36) 5.24 
Cadherin binding involved in cell-cell adhesion (45; 2.15) 5.09 
Regulation of protein transport (86; 1.62) 5.02 
Response to hypoxia (41; 2.07) 4.70 
Tissue migration (38; 2.26); epithelial cell migration (35; 2.16) 4.67 
Transforming growth factor beta receptor signalling pathway (28; 2.48) 4.45 
Innate immune response-activating signal transduction (35; 2.03); activation 
of innate immune response (35; 1.97); positive regulation of innate immune 
response (39; 1.88) 
3.79 
Signal transduction by protein phosphorylation (92; 1.48); (74; 1.53)  3.72 
Nuclear transport (50; 1.49) 2.49 
In utero embryonic development (42; 1.79); embryo development ending in 
birth or egg hatching (56; 1.35); chordate embryonic development (55; 1.34) 
2.29 
Regulation of peptide transport (28; 1.89); peptide hormone secretion (29; 
1.70); hormone transport (33; 1.52); hormone secretion (32; 1.53); signal 
release (38; 1.28) 
2.12 
Reproductive system development (46; 1.53); reproductive structure 




DOWN REGULATED  
Transcription regulation (180; 1.45); positive regulation of RNA biosynthetic 
process (118, 1.51); regulation of gene expression (300; 1.20);  
4.28 
Cell morphogenesis (101; 1.42) 2.38 
Endocrine and other factor-regulated calcium reabsorption (11; 4.85); 
Calcium Signalling pathway (19; 2.10) 
2.28 
Histone acetylation (18; 2.17) 2.09 
Blood circulation (41; 1.42) 1.72 
Positive regulation of ion transmembrane transporter activity (10; 2.53) 1.48 
Steroid binding (12; 2.31); steroid hormone receptor activity (8; 2.33); steroid 
hormone mediated signalling pathway (16; 1.55); cellular response to steroid 
hormone stimulus (20; 1.45) 
1.46 














































































































































































































































SUPPLEMENTAL FIGURES LEGENDS 
 
Supplemental Figure 1. Gene expression distance matrix of analyzed samples generated in 
Geneplotter library performed for comparisons: PGE2 (200 µg/infusion) vs. placebo (A) and 
PGE2 (200 µg/infusion ) + E2 (33.3 μg/infusion) vs. placebo. VSN-normalized microarray 
expression data was clustered based on pair wise correlation using all detectable probes. 
CTRL – endometrial samples collected from gilts assigned to the control groups (infusions of 
placebo to both uterine horns), EX_H – endometrial samples collected from gilts assigned to 
the experimental group (uterine horns receiving PGE2 (A) or PGE2+E2 infusions (B), EX_C 
– endometrial samples collected from gilts assigned to the experimental group (uterine horns 
receiving placebo infusion), cyclic – endometrial samples collected on day 12 of the estrous 
cycle, pregnant – endometrial samples collected on day 12 of pregnancy. In the control group, 
each horn received intrauterine placebo infusions. In experimental group, randomly selected 
horns within each gilt received hormonal infusions of PGE2 (200 µg/infusion) or PGE2 (200 
µg/infusion) simultaneously with E2 (33.3 µg/infusion) whereas the contralateral horn 
received placebo infusions. 
D
o
w
n
lo
a
d
e
d
 fro
m
 h
ttp
s
://a
c
a
d
e
m
ic
.o
u
p
.c
o
m
/b
io
lre
p
ro
d
/a
d
v
a
n
c
e
-a
rtic
le
/d
o
i/1
0
.1
0
9
3
/b
io
lre
/io
a
a
2
3
0
/6
0
4
4
0
7
1
 b
y
 U
n
iv
e
rs
ity
 o
f Z
u
ric
h
 u
s
e
r o
n
 0
4
 J
a
n
u
a
ry
 2
0
2
1
